_version_ 1811293281333542912
author Amit Saxena
Jill Buyon
Peter Izmirly
Robert Clancy
Philip Carlucci
Paula Rackoff
Michael Belmont
Anita Moon-Grady
Mala Masson
Kristina Deonaraine
Nicola Fraser
Colin Phoon
Ashley Roman
Christina Penfield
Young Mi Lee
Julie Nusbaum
Bruce Solitar
Fardina Malik
Rebecca Haberman
Ruben Acherman
Elena Sinkovskaya
Alfred Albuhamad
Majd Makhoul
Gary Satou
Nelangi Pinto
Lisa Howley
Stephanie Levasseur
Jyothi Matta
Christopher Lindblade
Andrew Rubenstein
Caitlin Haxel
Katherine Kohari
Joshua Copel
James Strainic
Tam Doan
Karla Bermudez-Wagner
Shreya Sunil Sheth
Stacy Killen
Theresa Tacy
Michelle Kaplinski
Bailey Drewes
Bettina Cuneo
author_facet Amit Saxena
Jill Buyon
Peter Izmirly
Robert Clancy
Philip Carlucci
Paula Rackoff
Michael Belmont
Anita Moon-Grady
Mala Masson
Kristina Deonaraine
Nicola Fraser
Colin Phoon
Ashley Roman
Christina Penfield
Young Mi Lee
Julie Nusbaum
Bruce Solitar
Fardina Malik
Rebecca Haberman
Ruben Acherman
Elena Sinkovskaya
Alfred Albuhamad
Majd Makhoul
Gary Satou
Nelangi Pinto
Lisa Howley
Stephanie Levasseur
Jyothi Matta
Christopher Lindblade
Andrew Rubenstein
Caitlin Haxel
Katherine Kohari
Joshua Copel
James Strainic
Tam Doan
Karla Bermudez-Wagner
Shreya Sunil Sheth
Stacy Killen
Theresa Tacy
Michelle Kaplinski
Bailey Drewes
Bettina Cuneo
author_sort Amit Saxena
collection DOAJ
first_indexed 2024-04-13T04:59:05Z
format Article
id doaj.art-9d750e3d82524320bfc3c699e0e7cd5e
institution Directory Open Access Journal
issn 2053-8790
language English
last_indexed 2024-04-13T04:59:05Z
publishDate 2022-12-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj.art-9d750e3d82524320bfc3c699e0e7cd5e2022-12-22T03:01:24ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-12-019Suppl 310.1136/lupus-2022-lupus21century.40619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent BlockAmit Saxena0Jill Buyon1Peter Izmirly2Robert Clancy3Philip Carlucci4Paula Rackoff5Michael Belmont6Anita Moon-Grady7Mala Masson8Kristina Deonaraine9Nicola Fraser10Colin Phoon11Ashley Roman12Christina Penfield13Young Mi Lee14Julie Nusbaum15Bruce Solitar16Fardina Malik17Rebecca Haberman18Ruben Acherman19Elena Sinkovskaya20Alfred Albuhamad21Majd Makhoul22Gary Satou23Nelangi Pinto24Lisa Howley25Stephanie Levasseur26Jyothi Matta27Christopher Lindblade28Andrew Rubenstein29Caitlin Haxel30Katherine Kohari31Joshua Copel32James Strainic33Tam Doan34Karla Bermudez-Wagner35Shreya Sunil Sheth36Stacy Killen37Theresa Tacy38Michelle Kaplinski39Bailey Drewes40Bettina Cuneo41Center for Musculoskeletal Care, New York University, New York, New York, USADivision of Rheumatology, Department of Medicine, New York University School of Medicine, New York, USA1 Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA1NYU Langone Health, USA1 Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, Maryland, USA1 Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA1NYU School of MedicineSchool of Medicine, University of California San Francisco, San Francisco, California, USA1Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY2University at Buffalo, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA1NYU Langone Health, USA3Children’s Heart Center, USA4East Virginia Medical School, USA4East Virginia Medical School, USA5University of Kentucky, USA6University of California, USA, Los Angeles, USA7University of Utah, USA9Midwest Fetal Care Center, Children’s Minnesota/Allina Health, USA10Columbia University, USA11University of Louisville, USA12Phoenix Children’s Hospital, USA13Dignity Health, USA14University of Vermont Children’s Hospital, USA15Yale University, USA15Yale University, USA16University Hospitals Rainbow Babies, USA17Baylor School of Medicine, USA17Baylor School of Medicine, USA17Baylor School of Medicine, USA18Vanderbilt University, USA19Stanford University, USA19Stanford University, USA20University of Colorado, Denver, USA20University of Colorado, Denver, USA
spellingShingle Amit Saxena
Jill Buyon
Peter Izmirly
Robert Clancy
Philip Carlucci
Paula Rackoff
Michael Belmont
Anita Moon-Grady
Mala Masson
Kristina Deonaraine
Nicola Fraser
Colin Phoon
Ashley Roman
Christina Penfield
Young Mi Lee
Julie Nusbaum
Bruce Solitar
Fardina Malik
Rebecca Haberman
Ruben Acherman
Elena Sinkovskaya
Alfred Albuhamad
Majd Makhoul
Gary Satou
Nelangi Pinto
Lisa Howley
Stephanie Levasseur
Jyothi Matta
Christopher Lindblade
Andrew Rubenstein
Caitlin Haxel
Katherine Kohari
Joshua Copel
James Strainic
Tam Doan
Karla Bermudez-Wagner
Shreya Sunil Sheth
Stacy Killen
Theresa Tacy
Michelle Kaplinski
Bailey Drewes
Bettina Cuneo
619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block
Lupus Science and Medicine
title 619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block
title_full 619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block
title_fullStr 619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block
title_full_unstemmed 619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block
title_short 619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block
title_sort 619 prospective evaluation of anti ssa ro positive pregnancies to address risk factors for fetal cardiac disease adverse pregnancy outcomes and efficacy of ambulatory fetal heart rate monitoring fhrm and rapid treatment of emergent block
work_keys_str_mv AT amitsaxena 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT jillbuyon 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT peterizmirly 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT robertclancy 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT philipcarlucci 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT paularackoff 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT michaelbelmont 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT anitamoongrady 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT malamasson 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT kristinadeonaraine 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT nicolafraser 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT colinphoon 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT ashleyroman 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT christinapenfield 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT youngmilee 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT julienusbaum 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT brucesolitar 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT fardinamalik 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT rebeccahaberman 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT rubenacherman 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT elenasinkovskaya 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT alfredalbuhamad 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT majdmakhoul 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT garysatou 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT nelangipinto 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT lisahowley 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT stephanielevasseur 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT jyothimatta 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT christopherlindblade 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT andrewrubenstein 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT caitlinhaxel 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT katherinekohari 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT joshuacopel 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT jamesstrainic 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT tamdoan 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT karlabermudezwagner 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT shreyasunilsheth 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT stacykillen 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT theresatacy 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT michellekaplinski 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT baileydrewes 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock
AT bettinacuneo 619prospectiveevaluationofantissaropositivepregnanciestoaddressriskfactorsforfetalcardiacdiseaseadversepregnancyoutcomesandefficacyofambulatoryfetalheartratemonitoringfhrmandrapidtreatmentofemergentblock